Search Results 151-160 of 16728 for CLL

1. Clinical trials - Oncology (Medical)

   Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

2. Duvelisib (oral route) - Mayo Clinic

   Duvelisib is used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or after 2 or more types of treatment that ...

3. Grzegorz S. Nowakowski, M.D. - Mayo Clinic Faculty Profiles

   Nowakowski is focused on the identification of novel prognostic markers in chronic lymphocytic leukemia using phage display peptide libraries. Dr ...

4. Lisocabtagene maraleucel (intravenous route) - Mayo Clinic

   Lisocabtagene maraleucel injection is also used to treat chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients who have ...

5. Publications

   Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index. Blood Cancer J 2021 ...

6. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

   ... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...

7. Macroglobulinemia Clinical Trials - Mayo Clinic Research

   ... (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas for ... chronic lymphocytic leukemia (CLL) or Waldenstrom's macroglobulinemia (WM).

8. Clinical trials - Oncology (Medical)

   The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...

9. Clinical trials - Oncology (Medical)

   ... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.

10. Clinical trials - Oncology (Medical)

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).